Decreasing the expression levels of SLC7A11 reduced the proliferation of MDA-MB-231 cells, and conversely, the addition of GluOC interfered with the inhibition of si SLC7A11 on cancer cells (Figure 2j). The gene discussed is SLC7A11; the disease is cancer.